Cargando…
Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case report
Coronavirus disease 2019 (COVID-19) began in December 2019 and has affected millions of people all over the world. Respiratory illness in the form of severe pneumonia, in addition to multiorgan failure and death, is the clinical spectrum of COVID-19. Although there are no specific therapeutic agents...
Autores principales: | Elboraey, Mohamed Omar, Essa, Emad El Said Fahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288232/ https://www.ncbi.nlm.nih.gov/pubmed/34384729 http://dx.doi.org/10.1016/j.oooo.2021.06.019 |
Ejemplares similares
-
Stevens-Johnson Syndrome
por: Laun, Jake, et al.
Publicado: (2016) -
Stevens-Johnson Syndrome Due to Influenza Vaccination
por: Tong, Jonathan, et al.
Publicado: (2020) -
Sinopharm COVID-19 vaccine-induced Stevens–Johnson syndrome
por: Boualila, L., et al.
Publicado: (2022) -
Stevens‐Johnson Syndrome due to COVID‐19 vaccination
por: Mansouri, Parvin, et al.
Publicado: (2021) -
Stevens Johnson Syndrome – “Steven Who? And Why I Should Care About His Johnson?”
por: Cardon, Zachary E., et al.
Publicado: (2019)